Liminal BioSciences Inc. (LMNL)

NASDAQ: LMNL · IEX Real-Time Price · USD
0.490
-0.010 (-2.00%)
At close: Aug 10, 2022 3:53 PM
0.471
-0.019 (-3.838%)
After-hours: Aug 10, 2022 7:52 PM EDT

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for LMNL stock is $1.08, which predicts an increase of 120.45%. The lowest target is $0.12 and the highest is $2.1. On average, analysts rate LMNL stock as a sell.
Analyst Consensus: Sell
Target Low Average Median High
Price $0.12 $1.08 $1.08 $2.1
Change -75.51% +120.45% +120.45% +328.66%

Analyst Ratings

The average analyst rating for LMNL stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating Feb '22Mar '22Apr '22May '22Jun '22Jul '22
Strong Buy 000000
Buy 000000
Hold 444444
Sell 111111
Strong Sell 222222
Total 777777

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.34
EPS Next Year
-0.23
Year 2017201820192020202120222023202420252026
Revenue
22.31M24.63M745.00K724.00K643.00K-----
Revenue Growth
36.12%
10.40%
-96.98%
-2.82%
-11.19%
-----
EPS
-137.85-235.95-12.81-4.830.43-0.34-0.23-0.15-0.20-0.26
EPS Growth
----------
No. Analysts -----43311

Revenue Forecast

Revenue 20222023202420252026
High n/a n/a n/a n/a n/a
Avg n/a n/a n/a n/a n/a
Low n/a n/a n/a n/a n/a

Revenue Growth

Revenue Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -

EPS Forecast

EPS 20222023202420252026
High -0.35 -0.24 -0.16 -0.21 -0.27
Avg -0.34 -0.23 -0.15 -0.20 -0.26
Low -0.32 -0.23 -0.15 -0.19 -0.26

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -